TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 SEK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 468,696 | 471,226 | 397,328 |
Financial expenses | 1,372 | 1,553 | 737 |
Earnings before taxes | 78,418 | 121,275 | 74,670 |
Total assets | 318,700 | 304,335 | 249,831 |
Current assets | 253,833 | 204,958 | 144,258 |
Current liabilities | 175,740 | 172,004 | 128,752 |
Equity capital | 140,251 | 129,377 | 116,835 |
- share capital | 7,192 | 6,964 | 6,804 |
Employees (average) | 22 | 21 | 21 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 44.0% | 42.5% | 46.8% |
Turnover per employee | 21,304 | 22,439 | 18,920 |
Profit as a percentage of turnover | 16.7% | 25.7% | 18.8% |
Return on assets (ROA) | 25.0% | 40.4% | 30.2% |
Current ratio | 144.4% | 119.2% | 112.0% |
Return on equity (ROE) | 55.9% | 93.7% | 63.9% |
Change turnover | -17,896 | 64,560 | -2,792 |
Change turnover % | -4% | 16% | -1% |
Chg. No. of employees | 1 | 0 | -9 |
Chg. No. of employees % | 5% | 0% | -30% |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.